Drug recall
Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter…
FDA recall event 75168 · Class II · Sandoz Inc
Key facts
| Event ID | 75168 |
|---|---|
| Recall numbers | D-0133-2017 |
| Recalling firm | Sandoz Inc |
| Product type | Drugs |
| Products | Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application. |
| Initiation date | Aug 24, 2016 |
| Report date | Nov 16, 2016 |
| Termination date | Jun 7, 2017 |
| City | Princeton |
| State | NJ |
| Country | United States |
| FEI number | 3011552892 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: